image class="left" url="http://media5.picsearch.com/is?IffHNIoouNIDhdT2OeagqSYhxjn0b_lw0YxnQjzF2t0&height=248"Our attorneys have filed a mass tort http://portaldewasa.fun lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical companies, such as the makers of Xarelto, have a duty to make sure that their drugs are reasonably safe for use - and failure to perform so could be grounds for compensation. Our lawyers are working difficult to have these hurt by the drug the compensation they are entitled to.













While bleeding can be a widespread complication linked with anticoagulants, it has been alleged that Xarelto is more unsafe than conventional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This indicates that, in the occasion of an emergency, patients could be at risk for irreversible bleeding problems, including life-threatening internal and gastrointestinal hemorrhaging.













If you or a loved one suffered a serious bleeding occasion following taking Xarelto, you might have legal recourse. For much more details, make contact with us today to have your case reviewed, totally free of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future medical bills, lost wages, pain and suffering and, in circumstances of death, funeral expenses. Moreover, they're looking for punitive damages, that are usually awarded to punish the defendant and deter other firms from acting similarly.






Why Are Lawsuits Being Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs inside the lawsuits allege critical and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of the drug continue to market Xarelto as a secure anticoagulant option.






Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.






Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.













Visit this page for much more data on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki